Merck KGaA (Merck KGaA) Sale Of Investment

: $549 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Merck KGaA's sale of investment for the three months ended in Dec. 2023 was $83 Mil. It means Merck KGaA gained $83 Mil from selling investments. Merck KGaA's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was $549 Mil.

Compared with last quarter ($178 Mil in Sep. 2023 ), Merck KGaA gained less money from selling investments in Dec. 2023 ($83 Mil).

Merck KGaA Sale Of Investment Historical Data

The historical data trend for Merck KGaA's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Investment

Get a 7-Day Free Trial

712.22

1,023.11

77.97

231.99

556.16

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Sale Of Investment	Get a 7-Day Free Trial															83.69	240.90	46.59	178.23	82.88

Merck KGaA Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $549 Mil.

Merck KGaA Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (Merck KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.